![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study
Publisher: Karger
E-ISSN: 1423-0232|67|3-4|250-256
ISSN: 0030-2414
Source: Oncology, Vol.67, Iss.3-4, 2004-11, pp. : 250-256
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract